Beauty Industry: Maintaining Fair Value Estimates; Selloff on Tariff News an Overreaction

Leading fashion brands are well-positioned to take tariff turmoil in stride.

Dan Su, CFA 4 April, 2025 | 9:45AM
Facebook Twitter LinkedIn

Collage illustration of a handbag, heels, and a watch, representing luxury items.

Editor's Note: This analysis was originally published as a stock note by Morningstar Equity Research.

Beauty Brands Hit by Global Market Selloff

Beauty names came under pressure following the Trump administration’s tariff announcements on April 2, mainly reflecting investor concerns over higher costs for products from Europe. US-based Estee Lauder EL and Coty CTY sold off 15% and 7%, respectively, while price movements were milder for Europe-based peers L’Oreal LOR (negative 2%) and Puig PUIG (negative 5%).

We acknowledge an extended period of such tariffs will likely impact financial results of beauty companies by pushing up costs and dampening demand. However, given the possibility of policy reversals pending US-EU negotiations, we are not incorporating the tariff scenario in our base-case valuation for now. Moreover, given considerable pricing power with gross margins averaging over 70% in our US and European beauty coverage, coupled with flexibility in global supply chains, we see room for beauty names to maneuver and offset the tariff impact. Specifically, Estee, L’Oreal, and Coty all have operated factories within the US for decades, which should afford flexibility to relocate production to lower tariff exposure. Small fragrance specialist Puig only has factories in Europe and India, but we expect the firm can leverage the high-end positioning of its European brands to pass on some of the tariff impact through price increases.

As such, we are maintaining our fair value estimates for wide-moat Estee ($120) and L’Oreal (EUR 410) as well as no-moat Coty ($9.6 and EUR 9.3) and Puig (EUR 22). While all four names are trading at discounts, we see Estee as presenting the most attractive risk/reward mix, trading 50% below our fair value estimate.


The author or authors do not own shares in any securities mentioned in this article. Find out about Morningstar's editorial policies.

The information contained within is for educational and informational purposes ONLY. It is not intended nor should it be considered an invitation or inducement to buy or sell a security or securities noted within nor should it be viewed as a communication intended to persuade or incite you to buy or sell security or securities noted within. Any commentary provided is the opinion of the author and should not be considered a personalised recommendation. The information contained within should not be a person's sole basis for making an investment decision. Please contact your financial professional before making an investment decision.

Facebook Twitter LinkedIn

About Author

Dan Su, CFA  Dan Su, CFA, is a senior stock analyst with Morningstar.

© Copyright 2025 Morningstar, Inc. All rights reserved.

Terms of Use        Privacy Policy        Modern Slavery Statement        Cookie Settings        Disclosures